Andrea Kjos

Academician, trained clinician: investigating the mystifying healthcare system and writing about professions; mother of 3 humans & a dog (she/her).

[Andrea Kjos @ALKjos]

@joeymattingly @Health_Affairs This. is. amazing.

[Lauren Olsen @laurendolsen]

Can confirm that medical students who majored in the humanities and interpretive social sciences have more empathy at matriculation and graduation than their STEM and positivistic social sciences peers. Check out @hanagebremariam & my paper here: https://t.co/V5dTxBRL5R

[Sociology of Health Professions Education @soc_hpe]

Andrea Kjos makes a compelling argument for investigating codes of ethics, since they are excellent artifacts through which to understand institutional/professional logics. #esshpe #meded

[Andrea Kjos @ALKjos]

According to Dr Weil, changing healthcare is going to take a grassroots social movement of our future health professionals #inspiration https://t.co/bp1D7KOqAt

[Marty Martin @drakepresident]

Dr. Andrew Weil - @DrWeil - delivers the keynote adresss for the @HarkinAtDrake Wellness Symposium @DrakeUniversity.

[Erik D Maki @ErikDMaki]

This is why pharmacies are closing https://t.co/ylL1nsaW7V

[Andrea Kjos @ALKjos]

Health Care In 2030: AI And The Shifting Role Of Your Pharmacist via @forbes https://t.co/4UWF3yOpTa

[Andrea Kjos @ALKjos]

I'm no economist, but I wish we could talk more about the employer-paid premiums tax exclusion. Alternative ideas are needed #Healthcare https://t.co/j7YvFCIoYU

[NYT Health @NYTHealth]

The biggest health-insurance subsidy of all -- and why Congress isn't touching it https://t.co/HIGdhkn1eO

[National Academies @theNASEM]

New report discusses the value of social, behavioral, and economic sciences to advancing the @NSF's mission https://t.co/sj6Hn8C3Tb

[Andrea Kjos @ALKjos]

Health care 3.0 is the next phase. Pharmacists will join the #zpack @ZDoggMD @Commpharmacy @IowaPharmacyIPA #IARX2017

[Erik D Maki @ErikDMaki]

Financing and Distribution of Pharmaceuticals in the United States | Clinical Pharmacy and Pharmacology | JAMA | https://t.co/PNE7UoBUdg

[Andrea Kjos @ALKjos]

When genomics meets insurance we'll get more issues in adverse selection: "New Gene Tests Pose a Threat to Insurers" https://t.co/IH98Jmt80H

[Andrea Kjos @ALKjos]

New report on another regulatory loop-hole to delay generic drugs from entering the US market. #DUSAPh17 https://t.co/pxQLnlOWU8

[NEJM @NEJM]

Perspective: A Citizen’s Pathway Gone Astray — Delaying Competition from Generic Drugs https://t.co/6nQLSSMKgH #HealthLaw

[Andrea Kjos @ALKjos]

Initiatives this year to make clinical trials more standardized, increasing efficiency. #DUSAPh17 https://t.co/lr9rkyRGyh

[FDA Law Blog @fdalawblog]

FDA and NIH Release Final Template for Clinical Trial Protocols - https://t.co/nivMjHyU9G

[Andrea Kjos @ALKjos]

"And drug companies and PBMs have started pointing fingers at one another to assign blame for ... high drug prices." #DUSAPh17 https://t.co/EUVWaut7or

[Iowa Pharmacy Association @IowaPharmacyIPA]

With a breakdown how each step in supply chain impacts a drug's price, good to share w/ patients & colleagues, etc. https://t.co/CuY9bhEi0V

[Andrea Kjos @ALKjos]

@cubit_181 Not the same, but here is the link to the one I mentioned: https://t.co/lOxZX21Pb0

[Andrea Kjos @ALKjos]

Here is the link to the APhA Institute on Alcoholism and Drug Dependencies I mentioned in class today: https://t.co/lOxZX21Pb0 #DUSAPh17

[Andrea Kjos @ALKjos]

@KaitlinBSAPh @HuffingtonPost This is great!

[Andrea Kjos @ALKjos]

Wow. #DUSAPh17 https://t.co/qIyMuRs8sb

[U.S. FDA @US_FDA]

We’re conducting research on naloxone labeling that will hopefully lead to its over the counter availability. -FDA Commissioner @ #RxSummit

[Andrea Kjos @ALKjos]

Happening this week: National Rx Drug Abuse and Heroin Summit. Follow the important conversations at #rxsummit #DUSAPh17

[Andrea Kjos @ALKjos]

The big problem of fake drugs #DUSAPh17 https://t.co/RDg9TELm1H